Virolfi 450mg Tablet

Virolfi 450mg Tablet

4286.0 INR/Pack

Product Details:

  • Pacakaging (Quantity Per Box) 28 Tablets per box
  • Dosage Form Tablet
  • Indication Prophylaxis of cytomegalovirus (CMV) infection in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT)
  • Origin of Medicine Imported
  • Salt Composition Letermovir
  • Drug Type Allopathic
  • Ingredients Letermovir 450mg
  • Click to view more
X

Virolfi 450mg Tablet Price And Quantity

  • 4286.0 INR/Pack
  • 5 Pack

Virolfi 450mg Tablet Product Specifications

  • 28 Tablets per box
  • Tablet
  • Antiviral medication for prevention of cytomegalovirus (CMV) infection
  • Adults
  • Letermovir 450mg
  • Prophylaxis of cytomegalovirus (CMV) infection in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT)
  • Tablets
  • Imported
  • Store below 30C, protect from light and moisture
  • Allopathic
  • Take as prescribed by your doctor, do not exceed recommended dose
  • 28 Tablets
  • As directed by the physician
  • Letermovir

Virolfi 450mg Tablet Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 700 Pack Per Week
  • 6 Days
  • Yes
  • If order is confirmed we will reimburse the sample cost
  • Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia
  • All India

Product Description

1. Technical Specifications

Attribute Details
Brand Name Virolfi Tablet
Generic Name Valganciclovir
Strength 450 mg per tablet
Dosage Form Oral Tablet
Packaging Size Typically 1030 tablets per strip or bottle
Packaging Type Blister packs or HDPE bottles
Medicine Type Allopathic, Antiviral
Manufacturer Zydus Cadila
Distributed By Authorized distributors

2. Product Description

Virolfi 450 mg Tablet is an oral antiviral medication that is converted into Ganciclovir in the body. It works by inhibiting cytomegalovirus (CMV) DNA replication, thereby preventing viral multiplication.
It is primarily prescribed for the treatment of CMV retinitis in adults with AIDS and for prevention of CMV infection in organ transplant recipients, especially when the donor is CMV-positive.


3. Product Highlights

Attribute Details
Therapeutic Category Antiviral (Nucleotide analog, prodrug of Ganciclovir)
Application Area CMV infections in immunocompromised patients (AIDS, transplant recipients)
Mechanism of Action Converted to Ganciclovir inhibits viral DNA polymerase
Administration Oral, must be taken with food to ensure proper absorption
Storage Conditions Store at room temperature (2025 C), away from moisture and sunlight

4. Therapeutic Uses

  • Treatment of CMV retinitis in AIDS patients

  • Prophylaxis of CMV infection in solid organ transplant recipients, usually during the first 100200 days post-transplant


5. Side Effects

Common:

  • Nausea, vomiting, diarrhea

  • Headache, fever

  • Fatigue, insomnia, appetite loss

  • Anemia, neutropenia, thrombocytopenia (low blood counts)

Serious / Severe:

  • Shortness of breath, swelling of legs

  • Seizures, decreased urine output

  • Severe allergic reactions, itching, back pain


6. Precautions

  • Kidney Function: Dose adjustments and regular monitoring required in renal impairment

  • Liver Function: Use cautiously in hepatic impairment

  • Pregnancy & Breastfeeding: Contraindicated due to risk of harm to fetus or infant; reliable contraception required during treatment and for at least 30 days after therapy

  • Drug Interactions:

    • Increased kidney toxicity with cidofovir and tenofovir alafenamide

    • Reduced effectiveness with maribavir

    • Increased infection risk with immunosuppressants (clozapine, infliximab, etanercept)

    • Increased blood-related toxicity with zidovudine



Key Benefits of Virolfi 450mg Tablet

Virolfi 450mg Tablet offers effective protection against cytomegalovirus (CMV) infection, specifically in adult patients who have undergone an allogeneic hematopoietic stem cell transplant (HSCT). By preventing CMV, it helps reduce the risk of serious complications, ensuring a healthier post-transplant recovery. Its antiviral action is clinically proven for prophylaxis when prescribed correctly by a physician.


How to Use Virolfi 450mg Tablet

Virolfi 450mg Tablet should be taken orally, as directed by your doctor. It is important not to exceed the prescribed dosage, and the tablets should be consumed whole without crushing or chewing. Regular adherence to the medication schedule and storing the tablets below 30C, away from moisture and light, are crucial for maintaining efficacy.


Safety and Storage Guidelines

Virolfi 450mg Tablet must not be used by individuals with known hypersensitivity to Letermovir or any tablet excipient. For safety, always consult the prescribing physician and keep these tablets out of reach of children. Proper storage conditions ensure potency throughout the shelf life; protect from direct sunlight and excessive moisture.

FAQs of Virolfi 450mg Tablet:


Q: What is Virolfi 450mg Tablet and how does it work?

A: Virolfi 450mg Tablet contains Letermovir, an antiviral agent that prevents cytomegalovirus (CMV) infection in adults who have received an allogeneic hematopoietic stem cell transplant. It works by inhibiting viral replication, thus lowering CMV-related risks.

Q: Who should use Virolfi 450mg Tablet?

A: Virolfi 450mg Tablet is recommended for adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant, as prescribed by a healthcare professional.

Q: When and how should I take Virolfi 450mg Tablet?

A: Take Virolfi 450mg Tablet orally, once daily, following your doctors specific instructions. Avoid exceeding the recommended dose, and swallow the tablet whole for optimal results.

Q: Where should I store Virolfi 450mg Tablet?

A: Store Virolfi 450mg Tablet below 30C, away from direct light and moisture, to preserve its effectiveness throughout its shelf life.

Q: What precautions should be taken before using Virolfi 450mg Tablet?

A: Do not use Virolfi 450mg Tablet if you have known hypersensitivity to Letermovir or any of the tablets excipients, and always seek your physicians guidance before starting the regimen.

Q: What are the main benefits of Virolfi 450mg Tablet?

A: Virolfi 450mg Tablet significantly reduces the risk of CMV infection and its associated complications in post-transplant patients, contributing to a safer and more successful recovery.

Q: Is Virolfi 450mg Tablet available for export and distribution in India?

A: Yes, Virolfi 450mg Tablet is imported and available for supply, distribution, export, and wholesale through authorized medical channels in India.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Tablets' category



Back to top